Microlabs E-liabrary

Product

Bilast Oral Solution

Enquire Now

Composition

Each ml of oral solution contains Bilastine 2.5 mg.

Features / Experimentation

Pediatric antihistaminic oral solution formulated for effective relief of allergic rhino-conjunctivitis and urticaria. Provides selective peripheral H1-receptor blockade with minimal sedative effects.

Indications

Indicated for the symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.

Pharmacodynamics

Bilastine is a selective peripheral H1-receptor antagonist with moderate to high affinity for histamine H1-receptors. It exhibits no significant affinity for muscarinic, serotonergic, dopaminergic, or noradrenergic receptors, thereby effectively reducing histamine-mediated allergic symptoms.

Dosage and administration

Children aged 6 to 11 years with body weight of at least 20 kg: 10 mg bilastine (4 ml oral solution) once daily for relief of allergic rhino-conjunctivitis and urticaria symptoms or as directed by the physician.

Contraindications

Contraindicated in patients with known hypersensitivity to bilastine or any component of the formulation.

Bilast Oral Solution

Related Products

Learning Resources

About us

Policies